SectorBiological Technology
Established Date11/01/2016
Listing Date09/07/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees7
Fiscal Year Ends31/12
Security TypeCommon stock
Office address6 Liberty Square, #2382, Boston, MA 02109
Business
IntroductionTransCode Therapeutics, Inc., was incorporated under the laws of the State of Delaware on January 11, 2016. The company is an RNA oncology company founded on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapies. RNA-based therapies are highly selective for their targets and have the potential to provide a range of targets in the human genome that were previously untreatable with drugs.
